Advertisement

Product › Details
HDP-101 (Heidelberg Pharma)
![]() |
Next higher product group | therapeutic antibody |
![]() |
Status | 2016-09-19 development pp existent |
![]() |
Organisation | Heidelberg Pharma GmbH |
Today | Heidelberg Pharma Research GmbH | |
Group | Heidelberg Pharma (Group) | |
Original research | Max Delbrück Center for Molecular Medicine (MDC) | |
Record changed: 2023-12-18 |
Advertisement

More documents for HDP-101 (Heidelberg Pharma)
- [1] Heidelberg Pharma AG. (11/29/23). "Press Release: Heidelberg Pharma Announces Changes to the Executive Management Board. CEO Dr. Jan Schmidt-Brand to Retire". Ladenburg....
- [2] Heidelberg Pharma AG. (2/28/22). "Press Release: Heidelberg Pharma and Huadong Announce Strategic Partnership, Including Equity Investment". Ladenburg....
- [3] Heidelberg Pharma AG. (2/17/22). "Press Release: Heidelberg Pharma AG Secures Financing Commitment From its Main Shareholder dievini (ad hoc)". Ladenburg....
- [4] Heidelberg Pharma AG. (4/27/20). "Press Release: Heidelberg Pharma AG Raises EUR 14.4 Million from Private Placement". Ladenburg....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement

» top